On May 24, 2023 BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, reported that the Company will participate in fireside chats at two upcoming investor conferences (Press release, BeiGene, MAY 24, 2023, View Source [SID1234631991]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31st at 12:00 pm ET; and
Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12th at 11:40 am ET

Live webcasts of these events can be accessed from the investors section of BeiGene’s website at View Source and archived replays will be available for 90 days following the events.